Sierra Health and Life Lower Extremity Prosthetics Coverage Update

Coverage Summary

Policy Lower Extremity Prosthetics (Policy No. 2026T0645M, effective April 1, 2026) defines medical necessity criteria and lists applicable HCPCS L-codes for UnitedHealthcare Commercial and Individual Exchange plans. The policy covers external lower extremity prosthetic devices when InterQual CP clinical criteria and the member's benefit plan requirements are met, and it applies only to external (not fully implanted) prostheses.

Coverage stance is mixed: standard external prostheses and many microprocessor knee components are addressed as potentially covered when clinical criteria and K-levels support use, while certain technologies are considered unproven / not medically necessary (e.g., bone-anchored percutaneous limb prostheses). The update for 04/01/2026 added HCPCS code L5992 to the applicable codes list.

Key facts

Effective dateApril 1, 2026

Policy statusCURRENT

Scope summaryDefines medical necessity, covered devices, exclusions, and applicable HCPCS L- and related codes for lower extremity prosthetic devices for UnitedHealthcare Commercial and Individual Exchange plans; includes technology assessments for bone-anchored prostheses and microprocessor-controlled components.

HCPCS codes updated (added in update)1 (L5992)

Evidence strengthHayes review: minimal support (limited/low-quality evidence for some technologies)

Medical-Necessity Criteria

Not Medically Necessary / Unproven Devices

The rationale for not medically necessary determinations is based on the policy's evidence review showing insufficient or low-quality evidence of efficacy and safety for some technologies and documented high complication rates in key studies. For example, bone-anchored (OPRA) systems report frequent infections, mechanical complications, and high revision rates in cohort studies and were judged by Hayes and ECRI assessments as having limited, low-quality, or inconclusive evidence.

Similarly, powered microprocessor ankle systems and some combined microprocessor-powered configurations lack consistent, high-quality comparative data demonstrating durable clinical benefit; small samples, short follow-up, methodologic limitations, and mixed results underpin the policy's determinations of unproven or not medically necessary for specified anatomies and K-levels.

Clinical Evidence & Coverage Implications

Key evidence summary and implications:

• Hayes evolving evidence reviews and ECRI assessments found limited, low-quality evidence for Osseointegrated/OPRA bone-anchored prostheses and noted high rates of infection and mechanical complications and high revision frequencies (supporting noncoverage/unproven status).

• Longitudinal cohort data (Hagberg et al. 2022, Hagberg et al. 2020, Brånemark 2019) show improvements in patient-reported outcomes but substantial adverse events: deep and superficial infections, frequent mechanical complications, and notable implant revision/removal rates (e.g., revision-free survival and high proportions with ≥1 mechanical complication).

• For microprocessor-controlled knees (MPKs), systematic reviews and randomized or comparative studies (Hahn 2021; Klenow 2024; Morgan 2024; Kaufman 2018 and others) provide evidence of benefit for higher-functioning ambulators (K3/K4) — reductions in falls, improved mobility and patient-reported outcomes — but evidence is insufficient or mixed for lower K-levels (K0–K2).

• Powered microprocessor ankle-foot devices and combined microprocessor-powered systems have small, heterogeneous studies (Herrin 2024; Rogers-Bradley 2024; Kannenberg 2022; Kim 2021) with methodological limitations; results are inconsistent and do not provide robust support for routine coverage, leading to conservative policy positions that are conditional or classify these technologies as unproven for specified indications.

Guideline Recommendations

FDA / Regulatory Information

Coding

Applicable HCPCS L-codes for Lower Extremity Prostheses and Additions (reference only)HCPCS

L5000	Partial foot, shoe insert with longitudinal arch, toe filler.
L5010	Partial foot, molded socket, ankle height, with toe filler.
L5050	Ankle, Symes, molded socket, SACH foot.
L5060	Ankle, Symes, metal frame, molded leather socket, articulated ankle/foot (SACH).
L5100	Below knee (BK), molded socket, shin, SACH foot.
L5105	Below knee (BK), plastic socket, joints and thigh lacer, SACH foot.
L5150	Knee disarticulation (or through knee), molded socket, external knee joints, shin, SACH foot.
L5160	Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, SACH foot.
L5200	Above knee (AK), molded socket, single axis constant friction knee, shin, SACH foot.
L5210	Above knee (AK), short prosthesis, no knee joint (stubbies), with foot blocks, no ankle joints, each.

1–10 of 199

1/20

Applicable HCPCS Codes (updated)HCPCS

L5992

Code added to applicable HCPCS codes list (document notes quarterly edits; L5992 was added).

Provider Actions

Documentation Required

Medical records documentation may be required

Benefit coverage is determined by the member specific benefit plan document and applicable laws. Medical records documentation may be required to assess whether the member meets the clinical criteria for coverage but does not guarantee coverage.

Billing Rule

Payment limited to device meeting minimum specifications

If more than one prosthetic device can meet the member's functional needs, benefits are available only for the prosthetic device that meets the minimum specifications for the member's needs. If the member purchases a prosthetic device that exceeds these minimum specifications, payment will be limited to the amount for the minimum device and the member is responsible for the difference.

Definitions

Term	Definition
Activities of Daily Living (ADLs)
Basic tasks needed to function such as bathing, grooming, dressing, toilet use, eating, and physical ambulation.
Instrumental Activities of Daily Living (IADLs)
Higher cognitive/complex activities related to independent living such as shopping, transportation, meal preparation, housecleaning, managing finances and medications.
CMS Modifiers/Medicare Functional Classification Level (MFCL)
Clinical assessment of rehabilitation potential using K0-K4 modifiers describing functional ambulation potential.
Microprocessor Controlled Ankle Foot Prosthesis
Device able to actively change ankle angle and identify gradients and stair ascent/descent via microprocessor control and sensors.
Myoelectric Prosthetic
Battery-powered prosthetic operated by electric motors activated through electrodes detecting myoelectric potentials.
OPRA
Osseointegrated Prostheses for the Rehabilitation of Amputees (bone-anchored percutaneous limb prosthesis).
POP
Percutaneous osseointegrated prosthesis (device/system in sin of osseointegration).
MPK / MCPK
Microprocessor-controlled prosthetic knee.
MFCL / K-level
Medicare Functional Classification Level (K0-K4) indicating prosthetic ambulation potential.

Evidence & Assessments

Reference	Key finding/summary
Hayes Evolving Evidence Review (OPRA, 2023; updated 2025)
Found limited low-quality evidence for OPRA with high rates of infection and mechanical complications; no clear support (no/unclear level of support).
ECRI assessment (2022)
Evidence inconclusive for OPRA; limited low-quality studies with frequent serious complications (infection, implant loosening).
Hagberg et al. (2022) OPRA cohort (n=51, 10-year)
Q-TFA improvements over 10 years; revision-free survival: implant revision 83%, deep infection 65%, mechanical complications 17% at 10 years; increasing mechanical complications over time.
Hagberg et al. (2020) OPRA cohort (n=111, up to 18 years)
Q-TFA improvements at multiple time points; 55% had ≥1 mechanical complication; ~40% had repeated fractures; fixture remained stable but complications common.
Klenow et al. (2024) RCT (Genium enhancements, n=26)
Reduced stumbles, decreased pain, and improvements in comfort and gait measures with MPK enhancements; small sample and limited generalizability.
Morgan et al. (2024) pilot RCT (early rehab, n=18; 15 completers)
MPK users had higher mobility and confidence scores vs NMPK at 3 months; feasibility study with small sample.
Systematic reviews / AHRQ / Hahn et al. (2018/2021)
Systematic reviews/AHRQ/Hahn: MPKs reduce falls and improve mobility in limited community ambulators (K2-K3) though heterogeneity and study limitations exist.
Hayes Evolving Evidence Review (Powered MPAs, 2022 updated 2024)
Minimal support for powered microprocessor prosthetic ankles (MPAs) for transtibial amputations; reviewed few small poor-quality studies; conclusions unchanged by updates.
Herrin et al. (2024)
Small uncontrolled study of powered prosthetic foot showed tuned vs untuned differences in gait metrics; suggests potential benefits but inadequate evidence.
Rogers-Bradley et al. (2024)
Variable-stiffness prosthesis increased push-off work (~26-30% at speeds) and decreased contralateral GRF (3.1-3.9%) vs passive device; small n=7.
Kannenberg et al. (2022) survey
Cross-sectional survey of past PwrAF users (n=46 analyzed) reported improvements in pain and mobility among current users vs recalled passive foot, but recall bias and responder limitations noted.

Revision History

2026-04-01material_changeLatest

Added HCPCS code L5992 to applicable codes list; archived previous policy version 2026T0645L.